Clinical Trial Update: A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Cenerimod for systemic lupus erythematosus; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Cenerimod (cenerimod)

Snippet

Sponsor: Viatris Innovation GmbH | Conditions: Lupus Erythematosus, Systemic | Phase 3 | Status: ACTIVE_NOT_RECRUITING